In search of the DFNA11 myosin VIIA low- and mid-frequency auditory genetic modifier

Otology and Neurotology

Volumn 29, Issue 6, 2008, Pages 860-867

  Kallman, Jeremy C ^a   Phillips, James O ^a   Bramhall, Naomi F ^a   Kelly, John P ^b   Street, Valerie A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

DFNA11; Electroretinography; Low frequency hearing loss; MYO7A; Single nucleotide polymorphisms

Indexed keywords

DNA; MYOSIN; MYOSIN VIIA; ATP2B2 PROTEIN, HUMAN; MEMBRANE PROTEIN; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; WOLFRAMIN PROTEIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DFNA11 GENE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EXON; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; LABORATORY TEST; MALE; PERCEPTION DEAFNESS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VESTIBULAR FUNCTION; CALORIC VESTIBULAR TEST; GENETICS; HORIZONTAL GENE TRANSFER; HOSPITALIZATION; PEDIGREE; POINT MUTATION; SEX DIFFERENCE; USHER SYNDROME; WOLFRAM SYNDROME;

CALORIC TESTS; GENE TRANSFER, HORIZONTAL; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MEMBRANE PROTEINS; MYOSINS; PEDIGREE; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; USHER SYNDROMES; WOLFRAM SYNDROME;

EID: 62349112355     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3181825651     Document Type: Article

References (35)

1. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 1991;630:16-31.
2. Van Camp G, Smith RJH. Hereditary Hearing Loss Homepage. Available at: http://dnalab-www.uia.ac.be/dnalab/hhh/. Accessed March 1, 2008.
3. Lalwani AK, Goldstein JA, Kelley MJ, et al. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet 2000;67:1121-8.
4. Donaudy F, Snoeckx R, Pfister M, et al. Nonmuscle myosin heavy-chain gene MYH14 is expressed in cochlea and mutated in patients affected by autosomal dominant hearing impairment (DFNA4). Am J Hum Genet 2004;74:770-6.
5. Donaudy F, Ferrara A, Esposito L, et al. Multiple mutations of MYO1A, a cochlear-expressed gene, in sensorineural hearing loss. Am J Hum Genet 2003;72:1571-7.
6. Walsh T, Walsh V, Vreugde S, et al. From flies' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc Natl Acad Sci U S A 2002; 99:7518-23.
7. Melchionda S, Ahituv N, Bisceglia L, et al. M-O6, the human homologue of the gene responsible for deafness in Snell's walter mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet 2001;69:635-40.
8. Weil D, Blanchard S, Kaplan J, et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995; 374:60-1.
9. Wang A, Liang Y, Fridell RA, et al. Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science 1998;280:1447-51.
10. Huxley HE. The mechanism of muscular contraction. Science 1969;164:1356-65.
11. Mermall V, Post PL, Mooseker MS. Unconventional myosins in cell movement, membrane traffic, and signal transduction. Science 1998;279:527-33.
12. Hasson T, Heintzelman MB, Santos-Sacchi J, et al. Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B. Proc Natl Acad Sci U S A 1995;92: 9815-9.
13. El-Amraoui A, Sahly I, Picaud S, et al. Human Usher 1B/mouse shaker-1: the retinal phenotype discrepancy explained by the presence/ absence of myosin VIIA in the photoreceptor cells. Hum Mol Genet 1996;5:1171-8.
14. Liu X, Vansant G, Udovichenko IP, et al. Myosin VIIa, the product of the Usher 1B syndrome gene, is concentrated in the connecting cilia of photoreceptor cells. Cell Motil Cytoskeleton 1997;37:240-52.
15. Hasson T, Gillespie PG, Garcia JA, et al. Unconventional myosins in inner-ear sensory epithelia. J Cell Biol 1997;137:1287-307.
16. Stenson PD, Ball EV, Mort M, et al. Human gene mutation database (HGMD): 2003 update. Hum Mutat 2003;21:577-81.
17. Tamagawa Y, Kitamura K, Ishida T, et al. Sensorineural hearing impairment non-syndromic, dominant DFNA11. Adv Otorhinolaryngol 2000;56:103-6.
18. Street VA, Kallman JC, Kiemele KL. Modifier controls severity of a novel dominant low frequency myosin VIIA (MYO7A) auditory mutation. J Med Genet 2004;41:e62.
19. Luijendijk MW, Van Wijk E, Bischoff AM, et al. Identification and molecular modelling of a mutation in the motor head domain of myosin VIIA in a family with autosomal dominant hearing impairment (DFNA11). Hum Genet 2004;115:149-56.
20. Bolz H, Bolz SS, Schade G, et al. Impaired calmodulin binding of myosin-7A causes autosomal dominant hearing loss (DFNA11). Hum Mutat 2004;24:274-5.
21. Di Leva F, D'Adamo P, Cubellis MV, et al. Identification of a novel mutation in the myosin VIIA motor domain in a family with autosomal dominant hearing loss (DFNA11). Audiol Neurootol 2006;11:157-64.
22. Schultz JM, Yang Y, Caride AJ, et al. Modification of human hearing loss by plasma-membrane calcium pump PMCA2. N Engl J Med 2005;352:1557-64.
23. Mohiddin SA, Ahmed ZM, Griffith AJ, et al. Novel association of hypertrophic cardiomyopathy, sensorineural deafness, and a mutation in unconventional myosin VI (MYO6). J Med Genet 2004; 41:309-14.
24. Osterhammel D, Osterhammel P. High-frequency audiometry. Scand Audiol 1979;8:73-81.
25. Street VA, Kallman JC, Robertson NG, et al. A novel DFNA9 mutation in the vWFA2 domain of COCH alters a conserved cysteine residue and intrachain disulfide bond formation resulting in progressive hearing loss and site-specific vestibular and central oculomotor dysfunction. Am J Hum Genet A 2005; 139:86-95.
26. Marmor MF, Arden GB, Nilsson SEG, et al. Standard for clinical electroretinography. Arch Ophthalmol 1989;107:816-9.
27. Marmor MF, Holder GE, Seeliger MW, et al. International society for clinical electrophysiology of vision. Standard for clinical electroretinography. Doc Opththalmol 2004;108:107-14.
28. Street VA, Robinson LC, Erford SK, et al. Molecular genetic analysis of distal mouse chromosome 6 defines gene order and positions of the deafwaddler and opisthotonos mutations. Genomics 1995;29:123-30.
29. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press, 2000:365-86.
30. Burland T. DNASTAR's Lasergene sequence analysis software. Methods Mol Biol 2000;132:71-91.
31. Bischoff AM, Pennings RJ, Huygen PL, et al. Cochleovestibular and ocular features in a Dutch DFNA11 family. Otol Neurotol 2006;27:323-31.
32. Smith RJ, Huygen PL. Making sense of nonsyndromic deafness. Arch Otolaryngol Head Neck Surg 2003;129:405-6.
33. Rhodes CR, Hertzano R, Fuchs H, et al. A Myo7a mutation cosegregates with stereocilia defects and low-frequency hearing impairment. Mamm Genome 2004;15:686-97.
34. Lynch ED, Lee MK, Morrow JE, et al. Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science 1997;278:1315-8.
35. Lesperance MM, Hall JWr, San Agustin TB, et al. Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2003;129: 411-20.